Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

Dear CBS Members, As you are aware, the COVID-19 pandemic has caused numerous disruptions around the world, and scheduled conferences are being either postponed or canceled...

We are very pleased to inform you that Dr. Paul Santerre has been selected by the Board of Directors of the Canadian Biomaterials Society CBS as the next recipient of the CBS Lifetime Achievement Award , acknowledging his outstanding contributions to our Society...

CBS is pleased to offer travel awards to assist students and post-doctoral fellows who are CBS members to present their accepted oral or poster abstracts at the 11th World Biomaterials Congress this May in Glasgow, Scotland...

The Fall 2019 edition of the CBS Newsletter is now available. Read about the latest initiatives from CBS, look back at the Quebec City CBS Annual Meeting and look ahead to WBC 2020 coming up this May in Glasgow, find out more about our very active student chapters across the country, meet the new CBS Senior Board Members and President-Elect, and learn more about the many award opportunities provided by CBS...

Biomaterials science study aims to improve devices in such way that, at physiological level, the tissue-biomaterial interface could have a strong integration...

Over 800 000 Canadians suffer from peripheral arterial disease PAD 1, a condition which leads to critical limb ischemia and high risks of amputation and mortality...

Coronary artery disease can lead to myocardial infarction, cardiomyocyte death, myocardium damage, and ultimately heart failure, due to the limited regenerative potential of cardiomyocytes CMs 1 ...

Recently, the prevention of hospital-acquired infections HAIs has increased to a great extent, due to an augmented awareness on the importance to reduce the spread of bacteria on everyday surfaces located, e...

Tumors contain heterogeneous and dynamic populations of cells that do not all display the fast- proliferating properties that traditional chemotherapies target...